Payne Susan L, Pei Xiao-fang, Jia Bin, Fagerness Angela, Fuller Frederick J
Department of Veterinary Pathobiology, Texas A&M University, College Station, Texas 77843-4467, USA.
J Virol. 2004 Mar;78(5):2478-85. doi: 10.1128/jvi.78.5.2478-2485.2004.
The molecular clones pSPeiav19 and p19/wenv17 of equine infectious anemia virus (EIAV) differ in env and long terminal repeats (LTRs) and produce viruses (EIAV(19) and EIAV(17), respectively) of dramatically different virulence phenotypes. These constructs were used to generate a series of chimeric clones to test the individual contributions of LTR, surface (SU), and transmembrane (TM)/Rev regions to the disease potential of the highly virulent EIAV(17). The LTRs of EIAV(19) and EIAV(17) differ by 16 nucleotides in the transcriptional enhancer region. The two viruses differ by 30 amino acids in SU, by 17 amino acids in TM, and by 8 amino acids in Rev. Results from in vivo infections with chimeric clones indicate that both LTR and env of EIAV(17) are required for the development of severe acute disease. In the context of the EIAV(17) LTR, SU appears to have a greater impact on virulence than does TM. EIAV(17SU), containing only the TM/Rev region from the avirulent parent, induced acute disease in two animals, while a similar infectious dose of EIAV(17TM) (which derives SU from the avirulent parent) did not. Neither EIAV(17SU) nor EIAV(17TM) produced lethal disease when administered at infectious doses that were 6- to 30-fold higher than a lethal dose of the parental EIAV(17). All chimeric clones replicated in primary equine monocyte-derived macrophages, and there was no apparent correlation between macrophage tropism and virulence phenotype.
马传染性贫血病毒(EIAV)的分子克隆体pSPeiav19和p19/wenv17在env和长末端重复序列(LTR)上存在差异,并分别产生具有显著不同毒力表型的病毒(分别为EIAV(19)和EIAV(17))。这些构建体被用于生成一系列嵌合克隆体,以测试LTR、表面(SU)和跨膜(TM)/Rev区域对高毒力EIAV(17)致病潜力的个体贡献。EIAV(19)和EIAV(17)的LTR在转录增强子区域相差16个核苷酸。这两种病毒在SU上相差30个氨基酸,在TM上相差17个氨基酸,在Rev上相差8个氨基酸。嵌合克隆体的体内感染结果表明,EIAV(17)的LTR和env对于严重急性疾病的发展都是必需的。在EIAV(17) LTR的背景下,SU对毒力的影响似乎比TM更大。仅含有无毒亲本的TM/Rev区域的EIAV(17SU)在两只动物中引发了急性疾病,而相似感染剂量的EIAV(17TM)(其SU来源于无毒亲本)则没有。当以比亲本EIAV(17)的致死剂量高6至30倍的感染剂量给药时,EIAV(17SU)和EIAV(17TM)均未产生致死性疾病。所有嵌合克隆体都在原代马单核细胞衍生的巨噬细胞中复制,并且巨噬细胞嗜性与毒力表型之间没有明显的相关性。